A 58-year-old man from rural India presents with nephrotic syndrome (proteinuria 8 g/day, serum albumin 2.1 g/dL, edema). Renal biopsy shows deposits that stain positive with Congo red and exhibit apple-green birefringence. Immunofluorescence microscopy shows no immunoglobulin or complement deposition. All of the following statements regarding amyloidosis in this patient are correct EXCEPT:

Explanation

## Diagnostic Approach to Systemic Amyloidosis ### Clinical Presentation & Initial Workup **Key Point:** While genetic testing for TTR mutations is important for hereditary amyloidosis, it is NOT the first-line diagnostic approach. The initial workup focuses on **typing the amyloid** using immunohistochemistry, immunofluorescence, and serum/urine studies. ### Correct Diagnostic Sequence ```mermaid flowchart TD A[Suspected Amyloidosis]:::outcome --> B[Congo red stain + Polarized light]:::action B --> C{Birefringence positive?}:::decision C -->|Yes| D[Confirm amyloid present]:::outcome D --> E[Immunofluorescence on biopsy]:::action E --> F{Immunoglobulin/Complement?}:::decision F -->|Negative| G[Likely AA or hereditary]:::outcome F -->|Positive| H[AL amyloidosis likely]:::outcome G --> I[Serum/urine immunofixation]:::action H --> I I --> J[Elevated monoclonal spike?]:::decision J -->|Yes| K[AL amyloidosis confirmed]:::outcome J -->|No| L[Consider AA or hereditary]:::outcome L --> M[Genetic testing if hereditary suspected]:::action ``` ### Why Genetic Testing is NOT First-Line **High-Yield:** Genetic testing for TTR mutations is: - Performed **after** amyloid type is narrowed down by immunohistochemistry and serum studies - Useful for confirming **hereditary transthyretin (hATTR) amyloidosis** — but this is relatively rare - Not the initial diagnostic step; it is a **confirmatory test** for a specific subtype ### Correct Diagnostic Hierarchy | Step | Test | Purpose | |------|------|----------| | 1 | Congo red stain + polarized light | Confirm amyloid | | 2 | Immunofluorescence on biopsy | Identify immunoglobulin/complement | | 3 | Serum/urine immunofixation | Screen for monoclonal protein (AL) | | 4 | Bone marrow biopsy (if AL suspected) | Detect plasma cell dyscrasia | | 5 | Genetic testing (TTR, apoA1, lysozyme) | Confirm hereditary amyloidosis | ### Clinical Context in This Case **Clinical Pearl:** The patient has: - Nephrotic syndrome with amyloid on biopsy - **Negative immunofluorescence** → rules out AL amyloidosis (light chain) - **No monoclonal spike** likely → suggests AA amyloidosis or hereditary form - In India, **AA amyloidosis** is more common due to high prevalence of chronic infections (TB, osteomyelitis) and chronic inflammation **Mnemonic: TYPE FIRST** — **T**issue diagnosis (Congo red), **Y**pe by immunofluorescence, **P**rotein studies (immunofixation), **E** — **E**lectron microscopy for confirmation, then **F**urther genetic testing if hereditary suspected, **I**nvestigate cause (TB, RA), **R**isk stratify, **S**upport organ function, **T**reat underlying disease.